Antisense oligonucleotide therapy in a humanized mouse model of MECP2 duplication syndrome is a research paper published in Science Translational Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 60 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1F32HD100048-01
Investigating the role of Growth-differentiation factor 11 in neurodevelopmental and MECP2-related disorders
National Institute of General Medical Sciences
Grant: R01-GM120033
National Institute of Neurological Disorders and Stroke
Grant: 5R01NS057819
National Institute of Neurological Disorders and Stroke
Grant: R01 NS100738
National Institute of Child Health and Human Development
Grant: 5U54HD083092
Cancer Prevention and Research Institute of Texas
Grant: RP170387
National Institutes of Health
Grant: 5R01NS057819-15
Molecular Pathogenesis Studies of Rett Syndrome
FWCI
6.48
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals